Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3674125014 | Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3674127018 | Benzocaine 5 mg and tyrothricin 1 mg oromucosal lozenge | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4558341000052118 | bensokain 5 milligram och tyrotricin 1 milligram, munhålesugtablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Compound anesthetic topical preparation | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Local anesthetic (substance) | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing benzocaine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing tyrothricin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Benzocaine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Tetracycline (substance) | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Tyrothricin | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing benzocaine and tyrothricin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | läkemedelsform för munhåla och/eller tandkött | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | läkemedel som innehåller bensokain, för orofaryngealt bruk | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Lozenge | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Oromucosal lozenge | true | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product manufactured as oromucosal dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 2 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has unit of presentation | Lozenge | true | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 2 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 1 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has basis of strength substance (attribute) | Tyrothricin | true | Inferred relationship | Some | 1 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | har täljarvärde som visar styrka | fem | false | Inferred relationship | Some | 2 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has precise active ingredient | Tyrothricin | true | Inferred relationship | Some | 1 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | har täljarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has precise active ingredient | Benzocaine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has basis of strength substance (attribute) | Benzocaine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | räkning av bas i aktiv ingrediens | två | false | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing only benzocaine and tyrothricin in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR